Arch Therapeutics Inc (ARTH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Arch Therapeutics Inc (ARTH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6529
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arch Therapeutics Inc (Arch Therapeutics) is a medical device company that develops self-assembling barrier technologies to improve interventional wound care outcomes. The company offers hemostasis and sealant products to seal and protect leaking and bleeding tissue. It provides interventional wound care products. Arch Therapeutics’ products are used for adhesion prevention, gastrointestinal anastomosis, burns, diabetic ulcers, pressure ulcers, ocular applications, and others. The company also develops AC5 topical gel, a self-assembling peptide (SAP) comprising naturally-occurring amino acids. Arch Therapeutics is headquartered in Framingham, Massachusetts, the US.

Arch Therapeutics Inc (ARTH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Arch Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Arch Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Arch Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Arch Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Arch Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Arch Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Arch Therapeutics Enters into R&D Agreement with Centre for Research in Medical Devices 10
Equity Offering 11
Arch Therapeutics Prices Private Placement of Shares and Warrants for USD4.5 Million 11
Arch Therapeutics Prices Public Offering of Units for USD6.1 Million 13
Arch Therapeutics to Raise up to USD3.4 Million in Private Placement of Units 14
Arch Therapeutics Raises USD3 Million in Private Placement of Units 15
Arch Therapeutics Completes Private Placement Of Shares For US$3 Million 16
Debt Offering 17
Arch Therapeutics Completes Private Placement Of Debt Securities For US$0.4 Million 17
Acquisition 18
Almah Completes Acquisition Of Arch Therapeutics In Reverse Takeover Transaction 18
Arch Therapeutics Inc – Key Competitors 19
Arch Therapeutics Inc – Key Employees 20
Arch Therapeutics Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Jul 20, 2018: Arch Therapeutics names Punit Dhillon as board director 22
Product News 23
Feb 02, 2017: Arch Therapeutics Announces Issuance of Method-of-Use Patent Covering Self-Assembling Peptidomimetics 23
Other Significant Developments 24
Jun 06, 2017: Arch Therapeutics Presents Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Arch Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Arch Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Arch Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Arch Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Arch Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Arch Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Arch Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Arch Therapeutics Enters into R&D Agreement with Centre for Research in Medical Devices 10
Arch Therapeutics Prices Private Placement of Shares and Warrants for USD4.5 Million 11
Arch Therapeutics Prices Public Offering of Units for USD6.1 Million 13
Arch Therapeutics to Raise up to USD3.4 Million in Private Placement of Units 14
Arch Therapeutics Raises USD3 Million in Private Placement of Units 15
Arch Therapeutics Completes Private Placement Of Shares For US$3 Million 16
Arch Therapeutics Completes Private Placement Of Debt Securities For US$0.4 Million 17
Almah Completes Acquisition Of Arch Therapeutics In Reverse Takeover Transaction 18
Arch Therapeutics Inc, Key Competitors 19
Arch Therapeutics Inc, Key Employees 20

List of Figures
Arch Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Arch Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Arch Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Arch Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Arch Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Arch Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Arch Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Arch Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Arch Therapeutics Inc (ARTH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Origin Energy Limited:企業の戦略・SWOT・財務情報
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AB Science SA (AB)-製薬・医療分野:企業M&A・提携分析
    Summary AB Science SA (ABS) is a pharmaceutical company that discovers, develops and commercializes tyrosine kinase inhibitor. The company concentrates its research on inflammatory diseases, cancers and central nervous system diseases in human and veterinary medicine. Its masitinib is an orally admi …
  • Armed Forces Insurance:企業の戦略的SWOT分析
    Armed Forces Insurance - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Apollo Consolidated Ltd (AOP):企業の財務・戦略的SWOT分析
    Summary Apollo Consolidated Ltd (Apollo) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, copper and nickel mineral deposits. Apollo holds exploration permits in Western Australia and Western Africa. The company …
  • Estel Technologies Pvt. Ltd:企業の戦略的SWOT分析
    Estel Technologies Pvt. Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Aprima Medical Software Inc-医療機器分野:企業M&A・提携分析
    Summary Aprima Medical Software Inc (Aprima) is an information technology service provider for pharmaceutical sector. The company’s solutions include EHR, practice management, and revenue cycle management. Its EHR solutions provide patient engagement, mobility, clinical decision support, integrated …
  • The Empire District Electric Company:発電所・企業SWOT分析
    The Empire District Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Aerovironment Inc
    Aerovironment Inc - Strategy, SWOT and Corporate Finance Report Summary Aerovironment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MGB Biopharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds. Its lead drug candidate MGB-BP-3 in the field of antibacterial resistance is active against may Gram-positive bacteria. MGB Biopharma a …
  • BKW AG:企業の戦略・SWOT・財務分析
    BKW AG - Strategy, SWOT and Corporate Finance Report Summary BKW AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Securities Trust of Scotland plc (STS):企業の財務・戦略的SWOT分析
    Summary Securities Trust of Scotland plc (Securities Trust of Scotland) is a financial service provider that offers capital asset services, broking services, online stock broking services, and online dealing. The company raises income and long term capital growth through investment in a portfolio of …
  • FTI Consulting, Inc.:企業の戦略・SWOT・財務情報
    FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report Summary FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BBA Aviation plc:企業の戦略・SWOT・財務情報
    BBA Aviation plc - Strategy, SWOT and Corporate Finance Report Summary BBA Aviation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pactiv LLC:企業の戦略・SWOT・財務情報
    Pactiv LLC - Strategy, SWOT and Corporate Finance Report Summary Pactiv LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務情報
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • 3W Power S.A. (3W9K):企業の財務・戦略的SWOT分析
    3W Power S.A. (3W9K) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BioRestorative Therapies Inc (BRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Public Broadcasting Service:企業の戦略・SWOT・財務分析
    Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report Summary Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Canada Post Corporation:企業の戦略・SWOT・財務情報
    Canada Post Corporation - Strategy, SWOT and Corporate Finance Report Summary Canada Post Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Greenbelt Resources Corp (GRCO):電力:M&Aディール及び事業提携情報
    Summary Greenbelt Resources Corp (GRC) is an alternative energy company that offers sustainable energy production systems delivering modular solutions that enable localized processing of locally generated waste into locally consumed products. The company designs, develops and implements technology t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆